|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06185 CANSINOBIO
Nominal 
31.760 0.000 (0.000%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Turnover | 546,653 | 46.130% | 374,088 | 285,420 | 21,086 | 629,790 |
| Cost of Sales | (133,186) | 71.835% | (77,508) | (98,269) | (797,573) | (313,617) |
| Gross Profit | 413,467 | 39.412% | 296,580 | 187,151 | (776,487) | 316,173 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (9,171) | -25.783% | (12,357) | (14,061) | (20,259) | (4,624) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (2,838) | 200.636% | (944) | (16,199) | 4 | 0 | |
| Profit / (Loss) before Taxation | 6,038 | -- | (19,303) | (229,196) | (1,283,335) | (41,555) | |
| Taxation | (6,759) | -- | 5,818 | (964) | 1,164 | 57,598 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 4,787 | 440,742 | (3,805) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (721) | -94.653% | (13,485) | (225,373) | (841,429) | 12,238 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 21,499 | 25.762% | 17,095 | (21,270) | (59,097) | (123,245) |
| Depreciation & Amortisation | 97,481 | 16.431% | 83,724 | 114,496 | 136,248 | 88,498 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| EPS (cts) | -0.290 | -94.200% | -5.000 | -91.000 | -341.000 | 5.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 20.150 | -- | 19.848 | 20.447 | 23.894 | 31.118 |
| Remarks: | Real time quote last updated: 31/08/2026 08:38 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -721 |
| %Change | -94.653% |
| EPS / (LPS) | RMB -0.003 |
| NBV Per Share (¥) | RMB 20.150 |